Trial Site Detail

 

Drug:
MEK162 + BYL719
Trial:
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Massachusetts General Hospital

100 Blossom St     
Charlestown , MA 02114
USA

 

Principal Investigator:
Dejan Juric, MD
Contact:
Kathleen Kelly 617-724-0865 kbkelly@partners.org
Activation Status of this Site:
Closed
Notes about this Site:
Massachusetts General Hospital Website:
http://www.massgeneral.org/cancer/clinical_trials/adult/search_trials.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.